Follow The Filings

QTWO Q2

Q2 earnings company data as of 4:45 AM ET 10/16

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.47 — —
Rev — — —

Insider trades

Open-market buys and sales by QTWO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All QTWO insider trades
  • None no insider bought on the open market
  • $5.1M sold by 1 insider outside a trading plan
  • $7.6M sold by 6 insiders under 10b5-1 plans
  1. Jonathan Price CFO
    Sale
    $5.1M 77,180 shares at $65.71 27% of stake
    Traded Aug 13 Filed Aug 14
  2. Kimberly Anne Rutledge Chief People Officer
    Planned sale
    $631K 10,000 shares at $63.07 8.1% of stake
    Traded Aug 10 Filed Aug 12
  3. Michael S Kerr General Counsel
    Planned sale
    $104K 2,071 shares at $50.33 4.4% of stake
    Traded Mar 11 Filed Mar 13
  4. Kimberly Anne Rutledge Chief People Officer
    Planned sale
    $161K 3,187 shares at $50.37 3.8% of stake
    Traded Mar 11 Filed Mar 13
  5. John E Breeden Chief Delivery Officer
    Planned sale
    $449K 8,924 shares at $50.34 11% of stake
    Traded Mar 11 Filed Mar 13
  6. Michael S Kerr General Counsel
    Planned sale
    $494K 9,554 shares at $51.66 16% of stake
    Traded Mar 5 Filed Mar 9
  7. Kimberly Anne Rutledge Chief People Officer
    Planned sale
    $1.1M 20,948 shares at $51.66 19% of stake
    Traded Mar 5 Filed Mar 9
  8. John E Breeden Chief Delivery Officer
    Planned sale
    $3.6M 68,707 shares at $51.73 43% of stake
    Traded Mar 5 Filed Mar 9
  9. Kirk L Coleman Chief Business Officer
    Planned sale
    $678K 12,917 shares at $52.48 4.8% of stake
    Traded Feb 17 Filed Feb 18
  10. Michael A. Volanoski Chief Revenue Officer
    Planned sale
    $387K 5,123 shares at $75.46 3% of stake
    Traded Dec 12, 2025 Filed Dec 12, 2025
  11. James Offerdahl Director
    Planned sale
    $56K 794 shares at $70.84 4.5% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 48 stock grants and 27 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 2.02,8.01,9.01
10-Q
8-K 5.07
SCHEDULE 13G/A —
SCHEDULE 13G —
DEF 14A
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.